BioMed Realty Announces Landmark Lease with Takeda at 585 Kendall to Accommodate Cambridge Expansion
Retrieved on:
Wednesday, June 22, 2022
Research, Commercial Building & Real Estate, Construction & Property, Finance, Professional Services, Biotechnology, General Health, Pharmaceutical, Health, Science, Solution, Heart, Wind, BIPOC, Senior, Water, Gold, LEED, Company, Research, Sluseholmen Canal District, BioMed Central, Cushman & Wakefield, Drug discovery, Ecosystem, CBRE, Kendall, 3rd Street, Leadership in Energy and Environmental Design, Color, Twitter, Kendall Square, United Kingdom, Multimedia, Blackstone, Childs Bertman Tseckares Inc., Construction, Retail, Interior design, Takeda
In addition to the community benefits provided by the project, BioMed and Takeda expect the building to achieve LEED Gold or higher designation.
Key Points:
- In addition to the community benefits provided by the project, BioMed and Takeda expect the building to achieve LEED Gold or higher designation.
- View the full release here: https://www.businesswire.com/news/home/20220621006130/en/
Takeda has signed a 600,000-square-foot lease in the heart of Cambridges thriving Kendall Square innovation ecosystem. - The building will also include more than 15,000 square feet of publicly accessible all-season flexible space and a 300+-seat theater.
- To learn more about BioMed Realty, visit biomedrealty.com and follow the company on Twitter @biomedrealty.